// App-Quantinova.ai

1539 : Risk of HER2-positive breast cancer among germline CHEK2 mutation carriers with breast cancer.

Researchers

Presenter

  • Chethan Ramamurthy

Principal Investigators

  • Raji Shameem

  • Andrea Forman

  • Jill S Dolinsky

  • Virginia Speare

  • Rachel E. McFarland

  • Wafik S. El-Deiry

  • Michael J. Hall

  • Mary Beryl Daly

  • Lori J. Goldstein

  • Elias Obeid

Medical Centers

  • Fox Chase Cancer Center, Philadelphia, PA

  • Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA

  • Ambry Genetics, Aliso Viejo, CA

  • Fox Chase Cancer Center, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • checkpoint kinase 2

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved